
	
Acetylcarnitine
From Wikipedia, the free encyclopedia
Acetylcarnitine
Clinical data
AHFS/Drugs.com
International Drug Names
Routes of
administration
Oral
ATC code
N06BX12 (WHO) 
Legal status
Legal status
In general: Over-the-counter (OTC)




Pharmacokinetic data
Bioavailability
>10%
Elimination half-life
28.9 - 35.9 hours[1]
Identifiers
IUPAC name
(R)-3-Acetyloxy-4-trimethylammonio-butanoate




CAS Number
3040-38-8 Y
PubChem CID
7045767
DrugBank
DB08842 Y
ChemSpider
5406074 Y
UNII
6DH1W9VH8Q
ChEBI
CHEBI:57589 Y
ChEMBL
ChEMBL1697733 Y
CompTox Dashboard (EPA)
DTXSID1040956 
ECHA InfoCard
100.130.594 
Chemical and physical data
Formula
C9H17NO4
Molar mass
203.236 g·mol−1
3D model (JSmol)
Interactive image
SMILES
[O-]C(=O)C[C@@H](OC(=O)C)C[N+](C)(C)C




InChI
InChI=1S/C9H17NO4/c1-7(11)14-8(5-9(12)13)6-10(2,3)4/h8H,5-6H2,1-4H3/t8-/m1/s1 Y
Key:RDHQFKQIGNGIED-MRVPVSSYSA-N Y




 NY (what is this?)  (verify)
Acetyl-L-carnitine, ALCAR or ALC, is an acetylated form of L-carnitine. It is naturally produced by the human body, and it is available as a dietary supplement. Acetylcarnitine is broken down in the blood by plasma esterases to carnitine which is used by the body to transport fatty acids into the mitochondria for breakdown.

Contents
1 Biochemical production and action
2 Health effects
3.1 Reviews
3.2 Studies




3 Research


4 References
5 Other reviews










Biochemical production and action[edit]
Carnitine is both a nutrient and made by the body as needed; it serves as a substrate for important reactions in which it accepts and gives up an acyl group. Acetylcarnitine is the most abundant naturally occurring derivative and is formed in the reaction:

acetyl-CoA + carnitine ⇌ CoA + acetylcarnitine
where the acetyl group displaces the hydrogen atom in the central hydroxyl group of carnitine.[2][3]  Coenzyme A (CoA) plays a key role in the Krebs cycle in mitochondria, which is essential for the production of ATP, which powers many reactions in cells; acetyl-CoA is the primary substrate for the Krebs cycle, once it is de-acetylated, it must be re-charged with an acetyl-group in order for the Krebs cycle to keep working.[3]

Most cell types appear to have transporters to import carnitine and export acyl-carnitines, which seems to be a mechanism to dispose of longer-chain moieties; however many cell types can also import ALCAR.[2]

Within cells, carnitine plays a key roles in importing acyl-CoA into mitochondria; the acyl-group of the acyl-CoA is transferred to carnitine, and the acyl-carnitine is imported through both mitochondrial membranes before being transferred to a CoA molecule, which is then beta oxidized to acetyl-CoA.  A separate set of enzymes and transporters also plays a buffering role by eliminating acetyl-CoA from inside mitochondria created by the pyruvate dehydrogenase complex that is in excess of its utilization by the Krebs cycle; carnitine accepts the acetyl moiety and becomes ALCAR, which is then transported out of the mitochondria and into the cytosol, leaving free CoA inside the mitochondria ready to accept new import of fatty acid chains.[3]  ALCAR in the cytosol can also form a pool of acetyl-groups for CoA, should the cell need it.[3]

Excess acetyl-CoA causes more carbohydrates to be used for energy at the expense of fatty acids.  This occurs by different mechanisms inside and outside the mitochondria.  ALCAR transport decreases acetyl-CoA inside the mitochondria, but increases it outside.[4][5]

Health effects[edit]
Carnitine and ALCAR supplements carry warnings of a risk that they promote seizures in people with epilepsy, but a 2016 review found this risk to be based only on animal trials.[6]

Research[edit]
Reviews[edit]
Peripheral neuropathy: Meta-analyses from 2015 and 2017 both conclude that the current evidence suggests ALC reduces pain from peripheral neuropathy with few adverse effects.[7] The 2017 review also suggested ALC improved electromyographic parameters.[8] Both called for more randomized controlled trials.  An updated Cochrane review in 2019 of four studies with 907 participants was very uncertain as to if ALC caused a pain reduction after 6 to 12 months of treatment.[9]
Chemotherapy-induced peripheral neuropathy (CIPN): A review of two studies concluded that ALC may be a treatment option for paclitaxel- and cisplatin-induced CIPN, while a clinical trial showed it did not prevent CIPN and appeared to worsen the conditions in taxane therapy.[10][11]
Male infertility: Scientific reviews from 2016 and 2014 showed mixed results, with some studies showing a positive relationship between ALC and sperm motility, and others showing no relationship.[12][13]
Dementia: A 2003 Cochrane review sought to determine the safety and efficacy of ALCAR in dementia but the reviewers found only clinical trials studies on Alzheimer's disease; the review found that the pharmacology of ALCAR was poorly understood and that based on the lack of efficacy, ALCAR was unlikely to be an important treatment for AD.[14]
Depression: One 2014 review assessed the use of ALCAR in fourteen clinical trials for various conditions with depressive symptoms; the trials were small (ranging from 20 to 193 subjects) and their design was so different that results could not be generalized; most studies showed positive results and a lack of adverse effects. The mechanism of action by which ALCAR could treat depression is not known.[15] A meta-analysis from 2014 concluded that ALCAR could only be recommended for the treatment of persistent depressive disorder if publication bias was deemed improbable.[16] A 2018 systematic review and meta-analysis of 12 randomized controlled trials found "supplementation significantly decreases depressive symptoms compared with placebo/no intervention, while offering a comparable effect with that of established antidepressant agents with fewer adverse effects." The review also indicates that "the effect of ALC in younger subjects was not more effective than placebo in improving these symptoms." indicating a need for more research explaining the age/effect relation.[17]
Fragile X syndrome: A 2015 Cochrane review of ALCAR in fragile X syndrome found only two placebo-controlled trials, each of low quality, and concluded that ALCAR is unlikely to improve intellectual functioning or hyperactive behavior in children with this condition.[18]
Hepatic encephalopathy: ALCAR has been studied in hepatic encephalopathy, a complication of cirrhosis involving neuropsychiatric impairment; ALCAR improves blood ammonia levels and generates a modest improvement in psychometric scores but does not resolve the condition — it may play a minor role in managing the condition.[19]







Studies[edit]
In a small clinical study, when ALCAR was administered intravenously and insulin levels were held steady and a meal low in carnitine but high in carbohydrates was taken by healthy young men, ALCAR appeared to decrease glucose consumption in favor of fat oxidation.[3]
References[edit]
^ Cao, Y; Wang, YX; Liu, CJ; Wang, LX; Han, ZW; Wang, CB (2009). "Comparison of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after single oral administration of L-carnitine in healthy volunteers". Clinical and Investigative Medicine. 32 (1): E13-9. doi:10.25011/cim.v32i1.5082. PMID 19178874.

^ a b Bieber LL (1988). "Carnitine". Annual Review of Biochemistry. 57: 261–83. doi:10.1146/annurev.bi.57.070188.001401. PMID 3052273.

^ a b c d e Stephens FB, Constantin-Teodosiu D, Greenhaff PL (June 2007). "New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle". The Journal of Physiology. 581 (Pt 2): 431–44. doi:10.1113/jphysiol.2006.125799. PMC 2075186. PMID 17331998.

^ Kiens B (January 2006). "Skeletal muscle lipid metabolism in exercise and insulin resistance". Physiological Reviews. 86 (1): 205–43. doi:10.1152/physrev.00023.2004. PMID 16371598.

^ Lopaschuk GD, Gamble J (October 1994). "The 1993 Merck Frosst Award. Acetyl-CoA carboxylase: an important regulator of fatty acid oxidation in the heart". Canadian Journal of Physiology and Pharmacology. 72 (10): 1101–9. doi:10.1139/y94-156. PMID 7882173.

^ Zeiler FA, Sader N, Gillman LM, West M (2016). "Levocarnitine induced seizures in patients on valproic acid: A negative systematic review". Seizure. 36: 36–39. doi:10.1016/j.seizure.2016.01.020. PMID 26889779.

^ Li, Sheyu; Li, Qianrui; Li, Yun; Li, Ling; Tian, Haoming; Sun, Xin (2015-01-01). "Acetyl-L-carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta-analysis of randomized controlled trials". PLOS ONE. 10 (3): e0119479. Bibcode:2015PLoSO..1019479L. doi:10.1371/journal.pone.0119479. ISSN 1932-6203. PMC 4353712. PMID 25751285.

^ N., Veronese (2017). "Effect of acetyl-l-carnitine in the treatment of diabetic peripheral neuropathy: A systematic review and meta-analysis". European Geriatric Medicine. 8 (2): 117–122. doi:10.1016/j.eurger.2017.01.002. hdl:10138/235591.

^ Rolim, Luiz Csp; da Silva, Edina Mk; Flumignan, Ronald Lg; Abreu, Marcio M.; Dib, Sérgio A. (15 June 2019). "Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy". The Cochrane Database of Systematic Reviews. 6: CD011265. doi:10.1002/14651858.CD011265.pub2. ISSN 1469-493X. PMC 6953387. PMID 31201734.

^ Schloss, Janet M.; Colosimo, Maree; Airey, Caroline; Masci, Paul P.; Linnane, Anthony W.; Vitetta, Luis (2013-12-01). "Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review". Clinical Nutrition (Edinburgh, Scotland). 32 (6): 888–893. doi:10.1016/j.clnu.2013.04.007. ISSN 1532-1983. PMID 23647723.

^ Brami, Cloé; Bao, Ting; Deng, Gary (February 2016). "Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review". Critical Reviews in Oncology/Hematology. 98: 325–334. doi:10.1016/j.critrevonc.2015.11.014. PMC 4727999. PMID 26652982.

^ Ahmadi, Sedigheh; Bashiri, Reihane; Ghadiri-Anari, Akram; Nadjarzadeh, Azadeh (2017-02-02). "Antioxidant supplements and semen parameters: An evidence based review". International Journal of Reproductive Biomedicine. 14 (12): 729–736. doi:10.29252/ijrm.14.12.729. ISSN 2476-4108. PMC 5203687. PMID 28066832.

^ Arcaniolo, Davide; Favilla, Vincenzo; Tiscione, Daniele; Pisano, Francesca; Bozzini, Giorgio; Creta, Massimiliano; Gentile, Giorgio; Menchini Fabris, Filippo; Pavan, Nicola (2014-09-30). "Is there a place for nutritional supplements in the treatment of idiopathic male infertility?". Archivio Italiano di Urologia e Andrologia. 86 (3): 164–170. doi:10.4081/aiua.2014.3.164. ISSN 1124-3562. PMID 25308577.

^ Hudson S, Tabet N (2003). "Acetyl-L-carnitine for dementia". Cochrane Database Syst Rev (Systematic review) (2): CD003158. doi:10.1002/14651858.CD003158. PMC 6991156. PMID 12804452.

^ Wang, Sheng-Min; Han, Changsu; Lee, Soo-Jung; Patkar, Ashwin A.; Masand, Prakash S.; Pae, Chi-Un (June 2014). "A review of current evidence for acetyl-l-carnitine in the treatment of depression". Journal of Psychiatric Research. 53: 30–37. doi:10.1016/j.jpsychires.2014.02.005. PMID 24607292.

^ Kriston, Levente; von Wolff, Alessa; Westphal, Annika; Hölzel, Lars P.; Härter, Martin (2014-08-01). "Efficacy and acceptability of acute treatments for persistent depressive disorder: a network meta-analysis". Depression and Anxiety. 31 (8): 621–630. doi:10.1002/da.22236. ISSN 1520-6394. PMID 24448972. S2CID 41163109.

^ Veronese N, Stubbs B, Solmi M, Ajnakina O, Carvalho AF, Maggi S (Feb–Mar 2018). "Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis". Psychosomatic Medicine. 80 (2): 154–159. doi:10.1097/PSY.0000000000000537. PMID 29076953. S2CID 7649619.

^ Rueda, JR;  et al. (May 2015). "L-acetylcarnitine for treating fragile X syndrome". Cochrane Database Syst Rev. 19 (5): CD010012. doi:10.1002/14651858.CD010012.pub2. PMID 25985235.

^ Jawaro, T.; Yang, A.; Dixit, D.; Bridgeman, M. B. (28 April 2016). "Management of Hepatic Encephalopathy: A Primer". Annals of Pharmacotherapy. 50 (7): 569–577. doi:10.1177/1060028016645826. PMID 27126547. S2CID 32765158.
























Other reviews[edit]
Jane Higdon, "L-Carnitine", Micronutrient Information Center, Linus Pauling Institute, Oregon State University
Carnitine (L-carnitine), University of Maryland Medical Center


v
t
e
Dietary supplements
Types
Amino acids
Bodybuilding supplement
Energy drink
Energy bar
Fatty acids
Herbal supplements
Minerals
Prebiotics
Probiotics (Lactobacillus
Bifidobacterium)
Protein bar
Vitamins















Vitamins and
chemical elements
 ("minerals")
Retinol (Vitamin A)
Thiamine (B1)
Riboflavin (B2)
Niacin (B3)
Pantothenic acid (B5)
Pyridoxine (B6)
Biotin (B7)
Folic acid (B9)
Cyanocobalamin (B12)








B vitamins

Ascorbic acid (Vitamin C)
Ergocalciferol and Cholecalciferol (Vitamin D)
Tocopherol (Vitamin E)
Naphthoquinone (Vitamin K)






Calcium
Choline
Chromium
Cobalt
Copper
Fluorine
Iodine
Iron
Magnesium
Manganese
Molybdenum
Phosphorus
Potassium
Selenium
Sodium
Sulfur
Zinc





















Other common 
ingredients
AAKG
β-hydroxy β-methylbutyrate
Carnitine
Chondroitin sulfate
Cod liver oil
Copper gluconate
Creatine
Dietary fiber
Echinacea
Elemental calcium
Ephedra
Fish oil
Folic acid
Ginseng
Glucosamine
Glutamine
Grape seed extract
Guarana
Iron supplements
Japanese honeysuckle
Krill oil
Lingzhi
Linseed oil
Lipoic acid
Milk thistle
Melatonin
Red yeast rice
Royal jelly
Saw palmetto
Spirulina
St John's wort
Taurine
Wheatgrass
Wolfberry
Yohimbine
Zinc gluconate







































Related articles
Codex Alimentarius
Enzyte
Hadacol
Herbal tea
Nutraceutical
Multivitamin
Nutrition










v
t
e
Antioxidants
Food antioxidants
6-Hydroxymelatonin
Acetyl-L-carnitine (ALCAR)
Alpha-lipoic acid (ALA)
Ascorbic acid (vitamin C)
Carotenoids (vitamin A)
Curcumin
Edaravone
Polyphenols
Glutathione
Hydroxytyrosol
L-carnitine
Ladostigil
Melatonin
Mofegiline
N-Acetylcysteine (NAC)
N-Acetylserotonin (NAS)
Oleocanthal
Oleuropein
Rasagiline
Resveratrol
Selegiline
Selenium
Tocopherols (vitamin E)
Tocotrienols (vitamin E)
Tyrosol
Ubiquinone (coenzyme Q)
Uric acid






























Fuel antioxidants
Butylated hydroxyanisole
Butylated hydroxytoluene
2,6-Di-tert-butylphenol
1,2-Diaminopropane
2,4-Dimethyl-6-tert-butylphenol
Ethylenediamine









Measurements
Folin method
ORAC
TEAC
FRAP







Acetylcholine receptor modulators
v
t
e
Muscarinic acetylcholine receptor modulators
mAChRs
Agonists
77-LH-28-1
AC-42
AC-260,584
Aceclidine
Acetylcholine
AF30
AF150(S)
AF267B
Alvameline
AQRA-741
Arecoline
Bethanechol
Bevonium
Butyrylcholine
Carbachol
CDD-0034
CDD-0078
CDD-0097
CDD-0098
CDD-0102
Cevimeline
Choline
cis-Dioxolane
Clozapine
Desmethylclozapine (norclozapine)
Ethoxysebacylcholine
Itameline
LY-593,039
L-689,660
LY-2,033,298
McNA343
Methacholine
Milameline
Muscarine
NGX-267
Ocvimeline
Oxotremorine
PD-151,832
Pilocarpine
RS86
Sabcomeline
SDZ 210-086
Sebacylcholine
Suberyldicholine
Talsaclidine
Tazomeline
Thiopilocarpine
Vedaclidine
VU-0029767
VU-0090157
VU-0152099
VU-0152100
VU-0238429
WAY-132,983
Xanomeline
YM-796



























































Antagonists
3-Quinuclidinyl benzilate
4-DAMP
Aclidinium bromide (+formoterol)
Abediterol
AF-DX 250
AF-DX 384
Ambutonium bromide
Anisodamine
Anisodine
Antihistamines (first-generation) (e.g., brompheniramine, buclizine, captodiame, chlorphenamine (chlorpheniramine), cinnarizine, clemastine, cyproheptadine, dimenhydrinate, dimetindene, diphenhydramine, doxylamine, meclizine, mequitazine, perlapine, phenindamine, pheniramine, phenyltoloxamine, promethazine, propiomazine, triprolidine)
AQ-RA 741
Atropine
Atropine methonitrate
Atypical antipsychotics (e.g., clozapine, fluperlapine, olanzapine (+fluoxetine), rilapine, quetiapine, tenilapine, zotepine)
Benactyzine
Benzatropine (benztropine)
Benzilone
Benzilylcholine mustard
Benzydamine
BIBN 99
Biperiden
Bornaprine
Camylofin
CAR-226,086
CAR-301,060
CAR-302,196
CAR-302,282
CAR-302,368
CAR-302,537
CAR-302,668
Caramiphen
Cimetropium bromide
Clidinium bromide
Cloperastine
CS-27349
Cyclobenzaprine
Cyclopentolate
Darifenacin
DAU-5884
Desfesoterodine
Dexetimide
DIBD
Dicycloverine (dicyclomine)
Dihexyverine
Difemerine
Diphemanil metilsulfate
Ditran
Drofenine
EA-3167
EA-3443
EA-3580
EA-3834
Emepronium bromide
Etanautine
Etybenzatropine (ethybenztropine)
Fenpiverinium
Fentonium bromide
Fesoterodine
Flavoxate
Glycopyrronium bromide (+beclometasone/formoterol, +indacaterol)
Hexahydrodifenidol
Hexahydrosiladifenidol
Hexbutinol
Hexocyclium
Himbacine
HL-031,120
Homatropine
Imidafenacin
Ipratropium bromide (+salbutamol)
Isopropamide
J-104,129
Hyoscyamine
Mamba toxin 3
Mamba toxin 7
Mazaticol
Mebeverine
Meladrazine
Mepenzolate
Methantheline
Methoctramine
Methylatropine
Methylhomatropine
Methylscopolamine
Metixene
Muscarinic toxin 7
N-Ethyl-3-piperidyl benzilate
N-Methyl-3-piperidyl benzilate
Nefopam
Octatropine methylbromide (anisotropine methylbromide)
Orphenadrine
Otenzepad (AF-DX 116)
Otilonium bromide
Oxapium iodide
Oxitropium bromide
Oxybutynin
Oxyphencyclimine
Oxyphenonium bromide
PBID
PD-102,807
PD-0298029
Penthienate
Pethidine
pFHHSiD
Phenglutarimide
Phenyltoloxamine
Pipenzolate bromide
Piperidolate
Pirenzepine
Piroheptine
Pizotifen
Poldine
Pridinol
Prifinium bromide
Procyclidine
Profenamine (ethopropazine)
Propantheline bromide
Propiverine
Quinidine
3-Quinuclidinyl thiochromane-4-carboxylate
Revefenacin
Rociverine
RU-47,213
SCH-57,790
SCH-72,788
SCH-217,443
Scopolamine (hyoscine)
Scopolamine butylbromide (hyoscine butylbromide)
Silahexacyclium
Sofpironium bromide
Solifenacin
SSRIs (e.g., femoxetine, paroxetine)
Telenzepine
Terodiline
Tetracyclic antidepressants (e.g., amoxapine, maprotiline, mianserin, mirtazapine)
Tiemonium iodide
Timepidium bromide
Tiotropium bromide
Tiquizium bromide
Tofenacin
Tolterodine
Tricyclic antidepressants (e.g., amitriptyline (+perphenazine), amitriptylinoxide, butriptyline, cidoxepin, clomipramine, desipramine, desmethyldesipramine, dibenzepin, dosulepin (dothiepin), doxepin, imipramine, lofepramine, nitroxazepine, northiaden (desmethyldosulepin), nortriptyline, protriptyline, quinupramine, trimipramine)
Tridihexethyl
Trihexyphenidyl
Trimebutine
Tripitamine (tripitramine)
Tropacine
Tropatepine
Tropicamide
Trospium chloride
Typical antipsychotics (e.g., chlorpromazine, chlorprothixene, cyamemazine (cyamepromazine), loxapine, mesoridazine, thioridazine)
Umeclidinium bromide (+vilanterol)
WIN-2299
Xanomeline
Zamifenacin





























































































































































Precursors
(and prodrugs)
Acetyl-coA
Adafenoxate
Choline (lecithin)
Citicoline
Cyprodenate
Dimethylethanolamine
Glycerophosphocholine
Meclofenoxate (centrophenoxine)
Phosphatidylcholine
Phosphatidylethanolamine
Phosphorylcholine
Pirisudanol















See also: Receptor/signaling modulators • Nicotinic acetylcholine receptor modulators • Acetylcholine metabolism/transport modulators
v
t
e
Nicotinic acetylcholine receptor modulators
nAChRs
Agonists
(and PAMs)
5-HIAA
6-Chloronicotine
A-84,543
A-366,833
A-582,941
A-867,744
ABT-202
ABT-418
ABT-560
ABT-894
Acetylcholine
Altinicline
Anabasine
Anatabine
Anatoxin-a
AR-R17779
Bephenium hydroxynaphthoate
Butinoline
Butyrylcholine
Carbachol
Choline
Cotinine
Cytisine
Decamethonium
Desformylflustrabromine
Dianicline
Dimethylphenylpiperazinium
Epibatidine
Epiboxidine
Ethanol (alcohol)
Ethoxysebacylcholine
EVP-4473
EVP-6124
Galantamine
GTS-21
Ispronicline
Ivermectin
JNJ-39393406
Levamisole
Lobeline
MEM-63,908 (RG-3487)
Morantel
Nicotine (tobacco)
NS-1738
PHA-543,613
PHA-709,829
PNU-120,596
PNU-282,987
Pozanicline
Pyrantel
Rivanicline
RJR-2429
Sazetidine A
SB-206553
Sebacylcholine
SIB-1508Y
SIB-1553A
SSR-180,711
Suberyldicholine
Suxamethonium (succinylcholine)
Suxethonium (succinyldicholine)
TC-1698
TC-1734
TC-1827
TC-2216
TC-5214
TC-5619
TC-6683
Tebanicline
Tribendimidine
Tropisetron
UB-165
Varenicline
WAY-317,538
XY-4083














































































Antagonists
(and NAMs)
18-MAC
18-MC
α-Neurotoxins (e.g., α-bungarotoxin, α-cobratoxin, α-conotoxin, many others)
ABT-126
Alcuronium
Allopregnanolone
Amantadine
Anatruxonium
AQW051
Atracurium
Barbiturates (e.g., pentobarbital, sodium thiopental)
BNC-210
Bungarotoxins (e.g., α-bungarotoxin, κ-bungarotoxin)
Bupropion
BW284C51
BW-A444
Candocuronium iodide (chandonium iodide)
Chlorisondamine
Cisatracurium
Coclaurine
Coronaridine
Curare
Cyclopropane
Dacuronium bromide
Decamethonium
Dehydronorketamine
Desflurane
Dextromethorphan
Dextropropoxyphene
Dextrorphan
Diadonium
DHβE
Dihydrochandonium
Dimethyltubocurarine (metocurine)
Dioscorine
Dipyrandium
Dizocilpine (MK-801)
Doxacurium
Encenicline
Enflurane
Erythravine
Esketamine
Fazadinium
Gallamine
Gantacurium chloride
Halothane
Hexafluronium
Hexamethonium (benzohexonium)
Hydroxybupropion
Hydroxynorketamine
Ibogaine
Isoflurane
Ketamine
Kynurenic acid
Laudanosine
Laudexium (laudolissin)
Levacetylmethadol
Levomethadone
Malouetine
ME-18-MC
Mecamylamine
Memantine
Methadone
Methorphan (racemethorphan)
Methyllycaconitine
Metocurine
Mivacurium
Morphanol (racemorphan)
Neramexane
Nitrous oxide
Norketamine
Pancuronium bromide
Pempidine
Pentamine
Pentolinium
Phencyclidine
Pipecuronium bromide
Progesterone
Promegestone
Radafaxine
Rapacuronium bromide
Reboxetine
Rocuronium bromide
Sevoflurane
Stercuronium iodide
Surugatoxin
Thiocolchicoside
Toxiferine
Tramadol
Trimetaphan camsilate (trimethaphan camsylate)
Tropeinium
Tubocurarine
Vanoxerine
Vecuronium bromide
Xenon


































































































Precursors
(and prodrugs)
Acetyl-coA
Adafenoxate
Choline (lecithin)
Citicoline
Cyprodenate
Dimethylethanolamine
Glycerophosphocholine
Meclofenoxate (centrophenoxine)
Phosphatidylcholine
Phosphatidylethanolamine
Phosphorylcholine
Pirisudanol















See also: Receptor/signaling modulators • Muscarinic acetylcholine receptor modulators • Acetylcholine metabolism/transport modulators






























Retrieved from "https://en.wikipedia.org/w/index.php?title=Acetylcarnitine&oldid=1031826513"


Acetate esters
Amino acid derivatives
Anti-aging substances
Salts of carboxylic acids
Dietary supplements
Quaternary ammonium compounds
Categories: 
Drugs with non-standard legal status
ECHA InfoCard ID from Wikidata
Chem-molar-mass both hardcoded and calculated
Articles without KEGG source
Drugboxes which contain changes to verified fields
Drugboxes which contain changes to watched fields
Hidden categories: 

		
		
		
		
		
		Jump to navigation
		Jump to search
		
		
	

	
	
	
	
	


	

Navigation menu

		Personal tools
	
Not logged in
Talk
Contributions
Create account
Log in

		
		
		
	

	
	


		Namespaces
	
Article
Talk

		
		
		
	

	
	


		Variants
	

		
		
		
	

	
	
	


			

			

		

		Views
	
Read
Edit
View history

		
		
		
	

	
	


		More
	

		
		
		
	

	
	
	

Search

		
	

			
			
			
			
		

		
	

	
	


			

			

			

		

		

		
		
	

		
	

		Navigation
	
Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate

		
		
		
	

	
	


		Contribute
	
Help
Learn to edit
Community portal
Recent changes
Upload file

		
		
		
	

	
	


		Tools
	
What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Wikidata item

		
		
		
	

	
	


		Print/export
	
Download as PDF
Printable version

		
		
		
	

	
	


		Languages
	
العربية
Español
Français
한국어
Hrvatski
Italiano
Português
Српски / srpski
Srpskohrvatski / српскохрватски
中文
Edit links

		
		
		
	

	
	


	
	

	



	



	
	
	



 This page was last edited on 3 July 2021, at 21:58 (UTC).
Text is available under the Creative Commons Attribution-ShareAlike License;
additional terms may apply.  By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.

	
	

Privacy policy
About Wikipedia
Disclaimers
Contact Wikipedia
Mobile view
Developers
Statistics
Cookie statement

	
	
	
	
	
	
	
	


	
	


	

	

	


















